retatrutide autoimmune disorders for Weight Loss: TRIUMPH-1 Results, Cost, Insurance Retatrutide vs. Tirzepatide: What's The

Your doctor will start you at 0.25 mg weekly and gradually increase to the maintenance dose of 2.4 mg

Then came the SOUL trial , which demonstrated that oral semaglutide also reduces MACE by 14% , establishing that the route of administration does not blunt the cardiovascular protection

If A1C is modestly elevated or glucose levels are close to target, proactive reductions in the doses of sulfonylureas and insulin may be prudent

others with severe symptoms should avoid it

First, the growing recognition that BMI is a flawed metric is driving conversations about alternative eligibility criteria

Limitations Not yet FDA-approved (as of 2025)